Key equity indices bounced from the day's low in mid-afternoon trade. FMCG shares declined for fourth sessions. The Nifty regained the 15,000 mark.
At 14:21 IST, the barometer index, the S&P BSE Sensex, was up 271.16 points or 0.54% to 50,712.23. The Nifty 50 index added 54.40 points or 0.36% at 15,010.60.
Sentiment was lifted by positive global cues. US Dow index futures was up 197 points, indicating a positive opening in the US stocks on Tuesday.
The broader market underperformed the benchmark indices. The S&P BSE Mid-Cap index slipped 1.10%. The S&P BSE Small-Cap index shed 0.92%.
Sellers outnumbered buyers. On the BSE, 1100 shares rose and 1819 shares fell. A total of 200 shares were unchanged.
Numbers to Track:
In the commodities market, Brent crude for May 2021 settlement rose 34 cents to $68.58 a barrel. The contract lost 1.16% or $1.12 to settle at $68.24 a barrel in the previous session.
The yield on 10-year benchmark federal paper fell to 6.214% as compared to its previous close of 6.223%.
In the foreign exchange market, the partially convertible rupee rose to 72.97, compared with its previous closing of 73.25.
MCX Gold futures for 5 April 2021 settlement added 0.55% to Rs 44,459.
The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, rose 0.33% to 91.942.
Buzzing Index:
The Nifty FMCG index was down 0.60% to 32,991.05, extending decline for fourth day. The index has lost 1.38% in four days while the benchmark Nifty 50 has declined by 1.73% during the same period.
Emami (down 3.45%), Tata Consumer Products (down 1.92%), Britannia Industries (down 1.59%), Jubilant Foodworks (down 1.40%), Godrej Consumer (down 1.60%), Dabur India (down 0.99%), Varun Beverages (down 0.90%), United Spirits (down 0.75%), Colgate-Palmolive India (down 0.62%) and Procter & Gamble Hygiene (down 0.49%) declined.
Meanwhile, United Breweries (up 1.49%) and Hindustan Unilever (up 0.37%) bucked the trend.
Stocks in Spotlight:
Solar Industries India fell 1.88% to Rs 1376.85. CRISIL has reaffirmed its 'CRISIL AA+/Stable/CRISIL A1+' ratings on the bank facilities and commercial paper of Solar Industries India (SIIL; a part of the Solar group).
Indoco Remedies rose 2.98% to Rs 284.85 after the drug company on Tuesday announced the launch of brinzolamide ophthalmic suspension, 1% in the US market. The suspension is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma. According to IQVIA data, the US market size of this product is $184 million as of December 2020.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
